Patents by Inventor Andrew Thomas Holder

Andrew Thomas Holder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5843453
    Abstract: Antigenic molecules cause antibodies to be raised against at least some of the 91 to 102 region of a natural growth hormone when parenterally administered in vivo. The molecules can include portions of the 91 to 102 region, particularly the 94 to 98 region. The antibodies are believed to bind to growth hormone on administration and enhance its effect.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: December 1, 1998
    Assignee: Biotechnology and Biological Sciences Research Council
    Inventors: Andrew Thomas Holder, James Beattie